Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
85.40
-1.57 (-1.81%)
At close: May 14, 2025, 4:00 PM
85.40
0.00 (0.00%)
After-hours: May 14, 2025, 7:00 PM EDT
PBH Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for PBH stock ranges from a low of $76 to a high of $104. The average analyst price target of $94 forecasts a 10.07% increase in the stock price over the next year.
Price Target: $94.00 (+10.07%)
Analyst Consensus: Buy
* Price targets were last updated on Mar 21, 2025.
Analyst Ratings
The average analyst rating for PBH stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 4 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Hold Maintains $96 → $97 | Hold | Maintains | $96 → $97 | +13.58% | Mar 21, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $87 → $93 | Buy | Maintains | $87 → $93 | +8.90% | Feb 13, 2025 |
DA Davidson | DA Davidson | Strong Buy Maintains $95 → $104 | Strong Buy | Maintains | $95 → $104 | +21.78% | Feb 7, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $93 → $100 | Strong Buy | Maintains | $93 → $100 | +17.10% | Feb 7, 2025 |
DA Davidson | DA Davidson | Strong Buy Maintains $95 | Strong Buy | Maintains | $95 | +11.24% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
1.14B
from 1.13B
Increased by 1.48%
Revenue Next Year
1.17B
from 1.14B
Increased by 2.28%
EPS This Year
4.55
from 4.17
Increased by 9.06%
EPS Next Year
4.82
from 4.55
Increased by 6.07%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 1.2B | 1.2B | 1.2B | |||
Avg | 1.1B | 1.2B | 1.2B | |||
Low | 1.1B | 1.1B | 1.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 5.6% | 6.7% | 6.8% | |||
Avg | 1.5% | 2.3% | 2.4% | |||
Low | -1.6% | -1.4% | -1.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 4.75 | 5.08 | 5.35 | |||
Avg | 4.55 | 4.82 | 5.08 | |||
Low | 4.41 | 4.58 | 4.74 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 13.8% | 11.7% | 11.0% | |||
Avg | 9.1% | 6.1% | 5.2% | |||
Low | 5.8% | 0.6% | -1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.